While reporting financial results for the first quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) reaffirmed its adjusted earnings and net sales guidance for the full year 2023.
from RTT - Earnings https://ift.tt/MXnOaLc
via IFTTT
No comments:
Post a Comment